glp-1 prostate cancer Emerging Evidence Positions Receptor Agonists as a Novel Strategy to Reduce CRC Risk May Patients Receiving GLP-1 Agonists

GI symptoms are independently associated with anxiety and depression, as well as diabetes-related stress, and they negatively affect quality of life

2017;26:620632 e626

Tryptophan metabolism by gut microbiome and gut-brain-axis: an in silico analysis

Nevertheless, understanding GI adverse events across both earlier and newer GLP-1based therapies remains highly relevant, particularly as these agents are increasingly prescribed for long-term and off-label indications

They work, but the cost alone can stop many people from even considering them

Lantidra (donislecel) developed by Chicago-based CellTrans, is a cell therapy made from the pancreatic islet cells of deceased donors